Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Lunning

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
JCO Global Oncology|October 22, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, et al.
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T ConsortiumMiriam T Jacobs, Michael D Jain, Feng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2019
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting ReportLucy B Cook, Shigeo Fuji, Olivier Hermine, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in OncologyKenneth C Anderson, Melissa Alsina, Djordje Atanackovic, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016Kenneth C Anderson, Melissa Alsina, Djordje Atanackovic, et al.
Blood|March 15, 2017
<i>Crebbp</i> loss cooperates with <i>Bcl2</i> overexpression to promote lymphoma in miceIdoia García-Ramírez, Saber Tadros, Inés González-Herrero, et al.
Blood|January 22, 2024
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapyJennifer L Crombie, Tara Graff, Lorenzo Falchi, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
JCO Global Oncology|October 22, 2025
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study GroupJason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, et al.
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T ConsortiumMiriam T Jacobs, Michael D Jain, Feng Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2019
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting ReportLucy B Cook, Shigeo Fuji, Olivier Hermine, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in OncologyKenneth C Anderson, Melissa Alsina, Djordje Atanackovic, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016Kenneth C Anderson, Melissa Alsina, Djordje Atanackovic, et al.
Blood|March 15, 2017
<i>Crebbp</i> loss cooperates with <i>Bcl2</i> overexpression to promote lymphoma in miceIdoia García-Ramírez, Saber Tadros, Inés González-Herrero, et al.
Blood|January 22, 2024
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapyJennifer L Crombie, Tara Graff, Lorenzo Falchi, et al.
Pageof 6